Damora Therapeutics, Inc. (DMRA)
21.49
-0.52
(-2.36%)
USD |
NASDAQ |
Oct 30, 16:00
21.48
0.00 (0.00%)
After-Hours: 20:00
Damora Therapeutics Market Cap : 1.327B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.327B |
| October 29, 2026 | 1.359B |
| October 28, 2026 | 1.334B |
| October 27, 2026 | 1.356B |
| October 26, 2026 | 1.313B |
| October 23, 2026 | 1.302B |
| October 22, 2026 | 1.341B |
| October 21, 2026 | 1.330B |
| October 20, 2026 | 1.276B |
| October 19, 2026 | 1.190B |
| October 16, 2026 | 1.139B |
| October 15, 2026 | 1.157B |
| October 14, 2026 | 1.138B |
| October 13, 2026 | 1.146B |
| October 12, 2026 | 1.251B |
| October 09, 2026 | 1.302B |
| October 08, 2026 | 1.270B |
| October 07, 2026 | 1.250B |
| October 06, 2026 | 1.207B |
| October 05, 2026 | 1.249B |
| October 02, 2026 | 1.275B |
| October 01, 2026 | 1.249B |
| September 30, 2026 | 1.314B |
| September 29, 2026 | 1.276B |
| September 28, 2026 | 1.281B |
| Date | Value |
|---|---|
| September 25, 2026 | 1.276B |
| September 24, 2026 | 1.252B |
| September 23, 2026 | 1.262B |
| September 22, 2026 | 1.384B |
| September 21, 2026 | 1.411B |
| September 18, 2026 | 1.395B |
| September 17, 2026 | 1.407B |
| September 16, 2026 | 1.515B |
| September 15, 2026 | 1.528B |
| September 14, 2026 | 1.753B |
| September 11, 2026 | 1.735B |
| September 10, 2026 | 1.657B |
| September 09, 2026 | 1.622B |
| September 08, 2026 | 1.801B |
| September 04, 2026 | 1.856B |
| September 03, 2026 | 1.729B |
| September 02, 2026 | 1.740B |
| September 01, 2026 | 1.738B |
| August 31, 2026 | 1.740B |
| August 28, 2026 | 1.791B |
| August 27, 2026 | 1.890B |
| August 26, 2026 | 1.877B |
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.872B |
| August 21, 2026 | 1.903B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.544B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 280.37M |
| Savara, Inc. | 990.03M |
| Vericel Corp. | 2.060B |
Market Cap Related Metrics
| PEG Ratio | -0.0002 |
| Price to Book Value | 3.437 |
| Price | 21.49 |
| Earnings Yield | -580.7% |
| PEGY Ratio | -0.0002 |